Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical study evaluates the safety and efficacy of mesenchymal stem cells in liver cirrhosis. It covers Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Liver Cirrhosis | Phase 1, Phase 2 | Status: UNKNOWN